Acute Treatment for Kawasaki Disease: Challenges for Current and Future Therapies

Affiliations

¹ Department of Pediatrics Labatt Family Heart Centre The Hospital for Sick Children University of Toronto Toronto, Ontario, Canada. Electronic address: brian.mccrindle@sickkids.ca.
² Division of Pediatric Cardiology Department of Pediatrics Lucile Packard Children's Hospital at Stanford Stanford University Medical Center Palo Alto, California.

Editorial

Brian W McCrindle et al. J Pediatr. 2017 May.

. 2017 May:184:7-10.

doi: 10.1016/j.jpeds.2017.01.072. Epub 2017 Feb 21.

¹ Department of Pediatrics Labatt Family Heart Centre The Hospital for Sick Children University of Toronto Toronto, Ontario, Canada. Electronic address: brian.mccrindle@sickkids.ca.
² Division of Pediatric Cardiology Department of Pediatrics Lucile Packard Children's Hospital at Stanford Stanford University Medical Center Palo Alto, California.

No abstract available

Keywords: acetylsalicylic acid; intravenous immunoglobulin; risk score.

Comment on

Efficacy of Four Scoring Systems in Predicting Intravenous Immunoglobulin Resistance in Children with Kawasaki Disease in a Children's Hospital in Beijing, North China.
Song R, Yao W, Li X. Song R, et al. J Pediatr. 2017 May;184:120-124. doi: 10.1016/j.jpeds.2016.12.018. Epub 2016 Dec 30. J Pediatr. 2017. PMID: 28043682
Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes.
Kim GB, Yu JJ, Yoon KL, Jeong SI, Song YH, Han JW, Hong YM, Joo CU. Kim GB, et al. J Pediatr. 2017 May;184:125-129.e1. doi: 10.1016/j.jpeds.2016.12.019. Epub 2016 Dec 30. J Pediatr. 2017. PMID: 28043685